These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35895752)

  • 1. TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance.
    Li Y; Wang T; Wan Q; Wang Q; Chen Z; Gao Y; Ye Y; Lin J; Zhao B; Wang H; Yang J; Zhao K; Lu N
    Cancer Res; 2022 Oct; 82(19):3573-3587. PubMed ID: 35895752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E3 Ubiquitin Ligase NEDD4-1 Mediates Temozolomide-Resistant Glioblastoma through PTEN Attenuation and Redox Imbalance in Nrf2-HO-1 Axis.
    Chuang HY; Hsu LY; Pan CM; Pikatan NW; Yadav VK; Fong IH; Chen CH; Yeh CT; Chiu SC
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.
    Yu T; Zhou F; Tian W; Xu R; Wang B; Zeng A; Zhou Z; Li M; Wang Y; Zhang J
    Oncogene; 2023 Feb; 42(6):461-470. PubMed ID: 36517590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioblastoma resistance to temozolomide.
    Xu X; Zheng Y; Luo L; You Z; Chen H; Wang J; Zhang F; Liu Y; Ke Y
    Cell Death Dis; 2024 May; 15(5):318. PubMed ID: 38710703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAF4 Promotes the Proliferation of Glioblastoma by Stabilizing SETDB1 to Activate the AKT Pathway.
    Gu H; Zhu S; Peng C; Wei Z; Shen Y; Yuan C; Yang H; Cui H; Yang L
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.
    Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G
    J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Key Role of DNA Damage-Inducible Transcript 4 (DDIT4) Connects Autophagy and GLUT3-Mediated Stemness To Desensitize Temozolomide Efficacy in Glioblastomas.
    Ho KH; Chen PH; Chou CM; Shih CM; Lee YT; Cheng CH; Chen KC
    Neurotherapeutics; 2020 Jul; 17(3):1212-1227. PubMed ID: 31916238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression.
    Zhou P; Peng X; Tang S; Zhang K; Tan Z; Li D; Shen L; Peng J; Yang L
    Oncogene; 2023 Apr; 42(16):1308-1320. PubMed ID: 36882523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANGPTL4 Induces TMZ Resistance of Glioblastoma by Promoting Cancer Stemness Enrichment via the EGFR/AKT/4E-BP1 Cascade.
    Tsai YT; Wu AC; Yang WB; Kao TJ; Chuang JY; Chang WC; Hsu TI
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
    Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA NEAT1 promotes malignant phenotypes and TMZ resistance in glioblastoma stem cells by regulating let-7g-5p/MAP3K1 axis.
    Bi CL; Liu JF; Zhang MY; Lan S; Yang ZY; Fang JS
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33057597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance.
    Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI
    Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients.
    Morelli MB; Nabissi M; Amantini C; Maggi F; Ricci-Vitiani L; Pallini R; Santoni G
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z; Wei X; Shen L; Zhu H; Zheng X
    Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP7 mediates TRAF4 deubiquitination to facilitate the malignant phenotype of ovarian cancer via the RSK4/PI3K/AKT axis.
    Wang Y; Luo X; Wu N; Liao Q; Wang J
    J Cancer Res Ther; 2023 Feb; 19(1):97-107. PubMed ID: 37006049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RUNX1 (RUNX family transcription factor 1), a target of microRNA miR-128-3p, promotes temozolomide resistance in glioblastoma multiform by upregulating multidrug resistance-associated protein 1 (MRP1).
    Xu J; Song J; Xiao M; Wang C; Zhang Q; Yuan X; Tian S
    Bioengineered; 2021 Dec; 12(2):11768-11781. PubMed ID: 34895074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines.
    Lombardi F; Augello FR; Artone S; Gugu MK; Cifone MG; Cinque B; Palumbo P
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.